Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP420988.RAKVT53QRRuHyS3rp915WmOmRVS9Ud1JkJs8BdzS4d4oE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP420988.RAKVT53QRRuHyS3rp915WmOmRVS9Ud1JkJs8BdzS4d4oE130_assertion type Assertion NP420988.RAKVT53QRRuHyS3rp915WmOmRVS9Ud1JkJs8BdzS4d4oE130_head.
- NP420988.RAKVT53QRRuHyS3rp915WmOmRVS9Ud1JkJs8BdzS4d4oE130_assertion description "[GCKR-L446 carriers are protected against type 2 diabetes despite higher triglyceride levels and risk of dyslipidemia, which suggests a potential molecular mechanism by which these two components of the metabolic syndrome can be dissociated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420988.RAKVT53QRRuHyS3rp915WmOmRVS9Ud1JkJs8BdzS4d4oE130_provenance.
- NP420988.RAKVT53QRRuHyS3rp915WmOmRVS9Ud1JkJs8BdzS4d4oE130_assertion evidence source_evidence_literature NP420988.RAKVT53QRRuHyS3rp915WmOmRVS9Ud1JkJs8BdzS4d4oE130_provenance.
- NP420988.RAKVT53QRRuHyS3rp915WmOmRVS9Ud1JkJs8BdzS4d4oE130_assertion SIO_000772 18556336 NP420988.RAKVT53QRRuHyS3rp915WmOmRVS9Ud1JkJs8BdzS4d4oE130_provenance.
- NP420988.RAKVT53QRRuHyS3rp915WmOmRVS9Ud1JkJs8BdzS4d4oE130_assertion wasDerivedFrom befree-20150227 NP420988.RAKVT53QRRuHyS3rp915WmOmRVS9Ud1JkJs8BdzS4d4oE130_provenance.
- NP420988.RAKVT53QRRuHyS3rp915WmOmRVS9Ud1JkJs8BdzS4d4oE130_assertion wasGeneratedBy ECO_0000203 NP420988.RAKVT53QRRuHyS3rp915WmOmRVS9Ud1JkJs8BdzS4d4oE130_provenance.